Logic-gated and contextual control of immunotherapy for solid tumors: contrasting multi-specific T cell engagers and CAR-T cell therapiesOlivier Nolan-Stevaux(Amgen (United States))Frontiers in ImmunologyNovember 13, 202410.3389/fimmu.2024.1490911Cited by 44SaveCiteExport RISWatch citationsRelated PapersEndoglin Requirement for BMP9 Signaling in Endothelial Cells Reveals New Mechanism of Action for Selective Anti-Endoglin Antibodies|PLoS ONE|2012|110